CHI3L1 and Alzheimer disease: In this search, plasma YKL-40 has been positioned as a promising candidate and a significant elevation was reported in mild AD-type dementia and early AD compared to controls [7, 18], but the significance of these findings in the differential diagnostic context of neurodegenerative dementias was unknown.